Mayo Clinic Doctor Says Mark Cuban’s Cost Plus Drugs is Bringing “Access” to U.S. Healthcare

 

Mark Cuban’s Cost Plus Drugs is making waves in the pharmacy market, gaining more than 1.2 million customers and selling over 1000 generic low-cost drugs at a fraction of the prescription price that Big Pharma puts on the marketplace. The big question now is whether the supply chain can fundamentally shift toward Cuban’s low-cost model as brand-name drugs resist the shift. Assistant Professor of Epidemiology for the Mayo Clinic College of Medicine at Mayo Clinic, Dr. Jose Medina-Inojosa, breaks down the ripple effects from the Cost Plus Drugs approach to drug product logistics.

Dr. Medina-Inojosa’s Thoughts

“Just to give you a little of context, as we all know, we are probably working in the best healthcare system of the world, but one of the major challenges that we have is access, and specifically prescription access is becoming a major problem in the United States. About 18 million people, about 7% of the whole United States, have a lot of trouble accessing medications and this company is probably gonna help some of the problems. They’re based in Dallas, they’re expanding access, they’re negotiating new deals with drug companies, getting access to generic medications that are about 85% cheaper. Talking about, to give you some example for some leukemia medications, it could take a drug from $2,500 to $14 at Mark Cuban’s Cost Plus Drugs, which is extremely exciting.

They’re also working with manufacturing their ordinary prescription medications in Dallas, and I think down the line they’re promising to continue to expand their deals and their reach over the next six or 12 months. So it’s not the major solution to fix all the problems, but I think it’s a really good step in the right direction. And I’m looking forward to see how it will help shape the face of healthcare and how it will help deliver access.”

Follow us on social media for the latest updates in B2B!

Image

Latest

healthcare
The Future of Employer Benefits: Balancing Rising Healthcare Costs with Creative, Employee-Centered Perks
August 28, 2025

The landscape of employee benefits has undergone a seismic shift in the last decade. From the rise of telemedicine to the introduction of lifestyle spending accounts and stipends for services like DoorDash and HelloFresh, employers are reimagining how they support workers in a post-pandemic, inflation-conscious world. With healthcare costs rising and talent competition intensifying,…

Read More
How Smart EHR Features Return Time to Patient Care: Insights from Healthcare Leaders
August 27, 2025

When Documentation Technology Finally Works for Clinicians At ChartLogic, we’ve spent years perfecting the features that matter most to healthcare providers. But rather than tell you what we think works, we wanted to hear directly from clinicians about the EHR capabilities that have genuinely improved their workflows. We asked healthcare professionals: Have you ever used…

Read More
sustainability
From Green Initiatives to Guest Loyalty: Building the Future of Hospitality Through Tree Planting and Plastic Cleanup Programs
August 27, 2025

Sustainability is no longer optional in hospitality—it’s the expectation. A recent Booking.com report found that 84 percent of global travelers now prioritize making their trips more sustainable, raising the bar for hotels worldwide. Yet too many properties are still relying on the basics—like towel reuse cards or energy-saving reminders—that guests increasingly see as table stakes….

Read More
The Future of Directional Drilling: How Emerging Technologies Are Reshaping Performance Standards
August 27, 2025

Driving Innovation in Energy Exploration At Altitude Energy Partners, we’ve long understood that the future of energy development depends on continuous innovation in directional drilling technology. As formations become more complex and environmental standards more stringent, the industry is experiencing a technological revolution that promises to redefine what’s possible in drilling performance. We asked industry…

Read More